• 2
  • 1
  • 3
  • 4
  • 5
1 2 3 4 5
simple jquery slider by WOWSlider.com v8.2
 
  NOVEDADES BIBLIOGRÁFICAS
     ALERTAS BIBLIOGRÁFICAS    |    ARTÍCULOS COMENTADOS 

 

 
ALERTAS BIBLIOGRÁFICAS
 

 

 

Older people with Type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies.
Hambling CE, Seidu SI, Davies MJ, Khunti K
Diabet Med. 2017 Sep;34(9):1219-1227.
http://dx.doi.org/10.1111/dme.13380.
Epub 2017 Jun 5.
Type 2 diabetes in adolescents and young adults.
Lascar N, Brown J, Pattison H, Barnett A, Bailey C, Bellary S
The Lancet Diabetes & Endocrinology Published Online
August 25, 2017
DOI: http://dx.doi.org/10.1016/S2213-8587(17)30186-9 
Alertas Anteriores


  The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis
Mirhosseini N; Vatanparast H; Mazidi M; Kimball S
The Journal of Clinical Endocrinology & Metabolism, Volume 102, Issue 9, 1 September 2017, Pages 3097–3110
https://doi.org/10.1210/jc.2017-01024
A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study.
González HE, Martínez JR, Vargas-Salas S, Solar A, Veliz L, Cruz F, Arias T, Loyola S, Horvath E, Tala H, Traipe E, Meneses M, Marín L, Wohllk N, Diaz RE, Véliz J, Pineda P, Arroyo P, Mena N, Bracamonte M, Miranda G, Bruce E, Urra S.
Thyroid. 2017 Aug;27(8):1058-1067. doi: 10.1089/thy.2017.0067. Epub 2017 Jul 11.
https://doi.org/10.1089/thy.2017.0067
Alertas Anteriores


 

Feeling misguided: a comment on the US guidelines on growth hormone and insulin-like growth factor-I treatment in children and adolescents.
Saenger P, Cohen P.
Curr Opin Pediatr. 2017 Aug;29(4):472-474.
doi: https://doi.org/10.1097/MOP.0000000000000520


To Prime or Not to Prime - Is That Still a Question? A Comment on the US Guidelines on Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents.
Lodefalk M, Nilsson O.
Horm Res Paediatr. 2017;88(2):179-180
doi: https://doi.org/10.1159/000475712
Epub 2017 May 15


Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence.
Grimberg A, Allen DB.
Curr Opin Pediatr. 2017 Aug;29(4):466-471.
doi: https://doi.org/10.1097/MOP.0000000000000505


Growth Promotion Ethics and the Challenge to Resist Cosmetic Endocrinology
.
Allen DB.

Horm Res Paediatr. 2017;87(3):145-152.
doi: https://doi.org/10.1159/000458526
Epub 2017 Mar 2.

Alertas Anteriores


 

Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing Disease.
Faucz F, Tirosh A, Tatsi C, Berthon A, Hernández-Ramírez L, Settas et al.
J Clin Endocrinol Metab, August 2017, 102(8):2836–2843

https://doi.org/10.1210/jc.2017-00161


Early-Onset Obesity: Unrecognized First Evidence for GNAS Mutations and Methylation Changes. Grüters-Kieslich A, Reyes M, Sharma A, Demirci C, DeClue TJ, Lankes E et al.
J Clin Endocrinol Metab, August 2017, 102(8):2670–2677
https://doi.org/10.1210/jc.2017-00395

 

Alertas Anteriores
SOCIEDAD CHILENA DE ENDOCRINOLOGÍA Y DIABETES
Bernarda Morín 488, Providencia, Santiago, Chile    Fonos: (56-2) 2753 5555 / (56-2) 2223 0386   Fax: (56-2) 2753 5556